概览
Dylan Goldstein is a biotech investor associated with Blackstone, providing equity funding to early-stage life sciences companies in the United States. He focuses on pre-seed and seed stage investments in the biotechnology sector, helping promising startups secure initial capital for development and growth. His investment approach targets emerging biotech ventures at their earliest funding stages.